Inicio
Notificación
Perfil
Artículos populares
Noticias
Historial de marcadores y "me gusta"
Centro de creador
Ajustes
Panda Traders
--
Seguir
$BTC
signal results 💸🔥🔥🔥
Dar propina
El creador recibió 0 propina(s).
Aviso legal: Se incluyen opiniones de terceros. Esto no representa una asesoría financiera. Puede haber contenido patrocinado.
Lee los TyC.
7.8k
0
Respuestas
4
Cotización
3
Conoce las noticias más recientes del sector
⚡️ Participa en los últimos debates del mundo cripto
💬 Interactúa con tus creadores favoritos
👍 Disfruta contenido de tu interés
Email/número de teléfono
Registrarse
Iniciar sesión
Creador relevante
Panda Traders
@Panda_Traders
Seguir
Explora más de este creador
Trump Coin: Next Target $20 or $100?
--
Hello $TRUMP holders ,I know many people Bought this coin at Very high price and how they are worried But here is a mews for you guys to get some relief $TRUMP is ready for a bullish Rally .It can give us good gains now .I will suggest you don't settle for less .Wait for bigg move 🔥🔥🔥🔥 It can easily move towards 100$ towards after breakout Keep holding ✍️ #Write2Earn #XRPHits3 #Trump2024 #TRUMPTokenWatch #TrumpCrypto
--
$VANA is just getting started 🚀 The V-shaped recovery is expected to gain momentum due to recent good news about #AI Who else in the whole market gave such bold and perfect call????🚀🚀🚀 #Write2Earn! #VanarChain
--
$BTC is dumping as predicted 💯 I told you guys about this dump 2 hours ago I hope you guys made some money 💰 This is how We predict daily $BTC target 🔥 Using this you can even make your own setup for short term profit gaining on Any coin you want #VeThorOnBinance #BTCNextATH? #BinanceAlphaAlert #BinanceAlphaAlert
--
$BTC next target 102792.28
--
Lo más reciente
USDC Treasury Issues 450 Million USDC in Recent Hours
--
Bitwise Seeks Registration For Dogecoin ETF In Delaware
--
Bitcoin(BTC) Drops Below 104,000 USDT with a 2.51% Decrease in 24 Hours
--
Larry Fink Warns Of Persistent Inflation Risks And Highlights AI Investment Needs
--
XRP And SOL Futures Set To Launch On CME Pending Regulatory Approval
--
Ver más
Mapa del sitio
Preferencias de cookies
Términos y condiciones de la plataforma